Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
General product and regulatory information only; this is not medical advice and not a handling or procedure guide. Facts below come from the cited public records, checked on 2026-10-31.
Short answer
Optisol is a brand of corneal storage medium made by Bausch + Lomb: a sterile, prescription-use liquid in which donor corneas are kept for a limited period before transplant. It is a storage medium, not tissue and not a drug. Optisol-GS has an FDA 510(k) record, K924165, with a 1992 decision date, in product code LYX, “Media, Corneal Storage”.
Definition and scope
Eye banks hold donor corneas in a storage medium between recovery and transplant (keratoplasty). Optisol-GS is described in a peer-reviewed study as “a commonly used medium for intermediate storage for corneal donor tissue in the United States” (Ho et al., Cornea 2020). The page you are reading covers what the product record says it is. It does not cover how a medium is used on tissue, and it gives no storage, handling or clinical instruction.
The regulatory identity of Optisol, record by record
Three public records identify the product. Together they show what the item is and under which FDA product code it sits.
| Record | What it states |
|---|---|
| NLM AccessGUDID, device 00757770601745 | Brand “Optisol”, model 50006-OPT, company Bausch + Lomb Incorporated, described as “Corneal Storage Media (Box of 12)”. Product code LYX, “Media, Corneal Storage”. Packaged sterile: yes. Prescription use: yes. Over-the-counter use: no. |
| FDA 510(k) database, K924165 | “OPTISOL-GS Corneal Storage Media”, applicant Chiron Intraoptics (Irvine, CA), decision date 10/06/1992, product code LYX. |
| FDA 510(k) K063304 (LIFE4C, decided 21 December 2007) | Names Optisol GS Corneal Storage Media (K924165) as its predicate. It is a different product in the same product code, LYX; its indication is the LIFE4C indication, not an Optisol label statement. |
The practical reading: a brand, a catalogue model number and a 510(k) number are three different identifiers. The 1992 clearance carries the Optisol-GS name, while the GUDID record carries the brand “Optisol” and model 50006-OPT under Bausch + Lomb. If you are matching an item on a requisition, a UDI record or an inventory list, match on the identifier each record actually uses. For background on the clearance route, see FDA 510(k) premarket notification; for how device records are keyed, see UDI medical device requirements.
How corneal storage media are compared in published studies
One small ex vivo study compared Optisol-GS with another medium, Cornea Cold, using 17 pairs of donor corneas, one of each pair in each medium, assessed at 7 and 21 days (Ho JW et al., Cornea 2020;39(8):1017-1019, PMC9187160). The table collects only what that paper reports.
| Item | Optisol-GS | Cornea Cold |
|---|---|---|
| Main colloidal osmotic agent | Dextran, “T-40” | Dextran, “T-500” |
| Storage duration noted in the paper | FDA approved for storage of corneal tissue for 14 days | Approved for up to 21 days in Europe |
| Endothelial cell loss and density at 7 and 21 days | Comparable between the two media | Comparable between the two media |
| Central corneal thickness | Lower at 7 days; 708 µm at 21 days | Higher at 7 days; 714 µm at 21 days, no longer different from Optisol-GS |
The same paper notes that Life4C and a medium called Chen are also FDA-approved for 14 days. The authors present a small laboratory comparison, so it supports “these two media performed comparably in this setup” and nothing wider.
Where it matters for labs, clinics and supply decisions
- Identify it by the record. The GUDID record lists the product as sterile and prescription-use, and it carries an FDA product code, so it is tracked as a regulated device item.
- Duration claims belong to the specific product. The 14-day figure is stated for FDA-approved media in the Ho et al. paper, and the indication wording in K063304 belongs to LIFE4C. Do not transfer one product’s indication to another.
- Related background. Donor corneas are human tissue, so the tissue bank entry is relevant context, and temperature-controlled storage is a general cold-chain topic. For the clinical field around corneal transplant, see what is ophthalmology.
Common misunderstandings
- “Optisol” is not the tissue. It is the liquid medium the tissue is stored in.
- It is not an over-the-counter product. AccessGUDID lists prescription use yes and over-the-counter no.
- Optisol and Optisol-GS are not interchangeable search terms in the records. The 510(k) uses “Optisol-GS”; the GUDID record uses the brand “Optisol”.
- One study is not a ranking. The comparison above shows comparable cell loss in one small study; it does not establish that one medium is better.
FAQ
Is Optisol FDA cleared?
The FDA 510(k) database lists OPTISOL-GS Corneal Storage Media under K924165 with a decision date of 10/06/1992, product code LYX.
Is Optisol sold over the counter?
No. AccessGUDID lists prescription use as yes and over-the-counter use as no for the Optisol record.
Who makes Optisol?
AccessGUDID lists Bausch + Lomb Incorporated as the company for brand “Optisol”, model 50006-OPT. The 1992 510(k) lists Chiron Intraoptics as the applicant.
What is product code LYX?
It is the FDA product code titled “Media, Corneal Storage” in AccessGUDID.
Did the published study show Optisol-GS is better than Cornea Cold?
No. In that 17-pair ex vivo study, endothelial cell loss and density were comparable between the two media.
Sources
Dates are when each record was checked.
- NLM AccessGUDID, device 00757770601745: https://accessgudid.nlm.nih.gov/devices/00757770601745 (checked 2026-10-31).
- FDA 510(k) database, K924165: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K924165 (checked 2026-10-31).
- FDA 510(k) K063304 (LIFE4C), FDA data mirror: https://fda.innolitics.com/device/K063304 (checked 2026-10-31).
- Ho JW et al. Cornea 2020;39(8):1017-1019: https://pmc.ncbi.nlm.nih.gov/articles/PMC9187160/ (checked 2026-10-31).







